BSE Live
Sep 30, 16:00Prev. Close
1309.50
Open Price
1344.00
Bid Price (Qty.)
1305.00 (100)
Offer Price (Qty.)
1323.90 (2)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
Profit & Loss account of Fredun Pharmaceuticals Limited (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 451.71 | 346.58 | 274.34 | 221.74 | 131.48 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 451.71 | 346.58 | 274.34 | 221.74 | 131.48 | |
Total Operating Revenues | 451.71 | 348.16 | 274.68 | 224.46 | 133.89 | |
Other Income | 4.56 | 0.92 | 1.82 | 1.63 | 1.40 | |
Total Revenue | 456.27 | 349.07 | 276.50 | 226.09 | 135.29 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 323.98 | 283.76 | 246.40 | 177.11 | 101.08 | |
Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Operating And Direct Expenses | 0.00 | 13.62 | 9.58 | 7.15 | 4.77 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | 6.05 | -22.44 | -37.72 | -0.01 | 1.17 | |
Employee Benefit Expenses | 22.23 | 12.50 | 11.53 | 10.66 | 8.66 | |
Finance Costs | 22.38 | 13.65 | 9.28 | 4.67 | 4.16 | |
Depreciation And Amortisation Expenses | 4.45 | 3.80 | 2.81 | 2.16 | 2.00 | |
Other Expenses | 48.91 | 22.73 | 17.10 | 15.75 | 9.08 | |
Total Expenses | 428.00 | 327.62 | 258.99 | 217.49 | 130.92 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 28.27 | 21.45 | 17.51 | 8.60 | 4.37 | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | -1.16 | |
Profit/Loss Before Tax | 28.27 | 21.45 | 17.51 | 8.60 | 3.21 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 7.46 | 5.54 | 4.29 | 2.21 | 0.76 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | 0.00 | 0.29 | 2.41 | 0.05 | 0.44 | |
Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Tax Expenses | 7.46 | 5.83 | 6.70 | 2.26 | 1.19 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 20.81 | 15.62 | 10.81 | 6.34 | 2.01 | |
Profit/Loss From Continuing Operations | 20.81 | 15.62 | 10.81 | 6.34 | 2.01 | |
Profit/Loss For The Period | 20.81 | 15.62 | 10.81 | 6.34 | 2.01 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 44.83 | 33.66 | 24.13 | 11.28 | 5.05 | |
Diluted EPS (Rs.) | 44.83 | 33.32 | 22.93 | 11.28 | 5.05 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 0.00 | 0.33 | 0.31 | 0.31 | 0.27 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 |
31.07.2025
Fredun Pharmace Standalone June 2025 Net Sales at Rs 119.40 crore, up 54% Y-o-Y
24.06.2025
Fredun Pharmace Standalone March 2025 Net Sales at Rs 165.44 crore, up 40.16% Y-o-Y
05.02.2025
Fredun Pharmace Standalone December 2024 Net Sales at Rs 101.84 crore, up 17.52% Y-o-Y
30.07.2024
Fredun Pharmace Standalone June 2024 Net Sales at Rs 77.54 crore, up 26.64% Y-o-Y
31.07.2025
Fredun Pharmace Standalone June 2025 Net Sales at Rs 119.40 crore, up 54% Y-o-Y
24.06.2025
Fredun Pharmace Standalone March 2025 Net Sales at Rs 165.44 crore, up 40.16% Y-o-Y
05.02.2025
Fredun Pharmace Standalone December 2024 Net Sales at Rs 101.84 crore, up 17.52% Y-o-Y
30.07.2024
Fredun Pharmace Standalone June 2024 Net Sales at Rs 77.54 crore, up 26.64% Y-o-Y